Clinical Study

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Assignment Study To Assess The Efficacy And Safety Of Reparixin In Pancreatic Islet Auto-Transplantation.

Posted Date: Aug 12, 2017

  • Investigator: Syed Ahmad
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to evaluate the safety and effectiveness of the study drug in patients who have undergone pancreatic islet auto-transplantation.


To Be Eligible Patients Must Have Been Diagnosed With Chronic Pancreatitis And Are Scheduled To Have Pancreas Removed And Have A Pancreatic Islet Auto-Transplant


Pancreatic Islet Auto-Transplantation, Chronic, Rep0112, Pancreatitis, Null

For More Information:

Uc Cancer Institute